Indazole derivatives that inhibit TRPV1 receptor

Details for Australian Patent Application No. 2006306146 (hide)

Owner Abbott Laboratories

Inventors Wang, Weili; Bayburt, Erol K.; Gomtsyan, Arthur R.; Lee, Chih-Hung; Brown, Brian S.; Marsh, Kennan C.; Schmidt Jr., Robert G.; Daanen, Jerome F.; Koenig, John R.

Agent Spruson & Ferguson

Pub. Number AU-A-2006306146

PCT Pub. Number WO2007/050732

Priority 60/730,991 28.10.05 US

Filing date 27 October 2006

Wipo publication date 3 May 2007

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/050732 Priority application(s): WO2007/050732

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306159-Internal olefins process

2006306140-Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists